Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

 News

Non à la violence à l’Hôpital, oui au respect 

Actualité (28/11/2023)  Non à la violence à l’Hôpital, oui au respect  L’Hôpital Universitaire de Bruxelles (H.U.B) lance une campagne de sensibilisation contre la violence au sein de ses hôpitaux, avec le message : 
“Unis contre la maladie, le respect est notre prescription pour de meilleurs soins.  
NON à la violence, OUI au respect !  
Ensemble, respectons-nous et prenons soin les uns des autres.”  Le respect constitue la…
(read more)

Join us in the fight against antimicrobial resistance!

News (20/11/2023)  Join us in the fight against antimicrobial resistance! Global Antimicrobial Resistance Awareness Week (18-24 November 2023). Antimicrobial resistance has become one of the biggest health challenges of recent years. The teams at H.U.B. are putting it at the heart of their action this week for Global Antimicrobial Resistance Awareness Week.  What is antimicrobial resistance?
Antimicrobials have revolutionised the…
(read more)

Changes to the procedure for sending paper medical documents

News (08/11/2023) Changes to the procedure for sending paper medical documents From November 2nd, the 3 hospitals that make up the H.U.B (Institut Jules Bordet, Hôpital Erasme and HUDERF) will stop systematically sending medical documents in paper format.  This decision is the result of developments in technology and the means of communication available in the health sector.  However, it is important to stress that anyone, whether a patient…
(read more)

Movember 2023

Press release (02/11/2023) Movember, a campaign to boost awareness  of male cancers Brussels – November 2nd 2023 – This year as every year, the month of November is a month dedicated to increasing awareness of males cancers with the Movember campaign.  Although generally less aware of the fact, men are also at risk of developing a cancer at some point in their lives.  The chances of survival are nevertheless high if the disease is detected at…
(read more)

Did you take your ID card?

News (30/10/2023)

Did you take your ID card? Did you know? One trip to the hospital = one presentation of electronic ID (eID, ISI+ card or KidsID if the patient is a child). If you are accompanying someone close to you, you must present the identity card of the person who has the appointment. Presenting the card is already compulsory for identity monitoring reasons: it helps us to ensure that we are providing the right care to the…
(read more)

Pink October - A personalised support programe for patients after breast cancer

Press Release (10/10/2023)  Pink October - A personalised support programe for patients after breast cancer Brussels, le 10 october 2023 - Thanks to improved screening and treatment, more and more patients are being cured of cancer. Nevertheless, the effects of the disease and its treatment can endure for months or even years after treatment ends. The Institut Jules Bordet has developed the RESTART programme, which offers patients with breast…
(read more)

Pink October : Artificial intelligence for breast cancer screening

Press Release (29/09/2023)  Pink October : Artificial intelligence for breast cancer screening Brussels, 29 September 2023 – This year as every year, October is the month to boost awareness of breast cancer. Breast cancer affects more than 10,000 women a year in Belgium, making it the number one cause of cancer deaths among women. Nevertheless, the likelihood of surviving breast cancer is high if the disease is detected at an early stage. The…
(read more)

Lung cancer: standardize practices for the benefit of the patient

News (28/09/2023) Lung cancer: standardize practices for the benefit of the patient During the World Conference on Lung Cancer (WCLC) held in Singapore from September 9 to 12, Dr. Mariana Brandao, medical oncologist at the Jules Bordet Institute, was able to present a new consensus definition to define the resectability of stage III non-small cell lung cancers, the result of long-term work carried out by many eminent members of thoracic…
(read more)

Importance of multidisciplinary care for head and neck cancers 

News (19/09/2023) The importance of multidisciplinary care for head and neck cancers  Risk factors and warning signs for “head and neck” cancers
“Head and neck” cancers cover all the tumours that develop in the upper aero-digestive tract or ENT: tongue, palate, nose, sinus, throat, larynx, pharynx, etc. Three risk factors have been clearly identified and they are all avoidable: tobacco, alcohol and the sexually transmissible…
(read more)

A new treatment option for patients with haematological cancers

News (09/08/2023) A new treatment option for patients with haematological cancers  The Jules Bordet Institute is now one of 7 Belgian centres to propose treatment with CAR-T cells for haematological cancer patients.  There are a number of treatments available for haematological cancers: chemotherapy, immunotherapy, radiotherapy, stem cell grafts and also cell therapy. Today, thanks to its cell therapy unit, the Jules Bordet Institute is able…
(read more)